HTAi 2018 – Panel Session Reports


Two new reports stemming from panel sessions at the 2018 Annual Meeting in Vancouver have been released.

The first report, Multi-Stakeholder Dialogues Addressing Needs, HTA Requirements and Good Practises in Emerging Countries, was from a panel organized by Dr. Alicia Granados.
Some of the key points that are highlighted in the report are:

  • Multi-stakeholder collaboration is a journey during which trust must be built to openly discuss difficult issues.
  • Stakeholder involvement needs to be organized in a transparent way that considers which stakeholder is involved in what way in each phase of the HTA process and this needs to be adequately resourced.
  • A range of mechanisms exist in the World Health Organization that enable effective multi-stakeholder collaborations and for HTA these include establishment of partnerships to build capacity in HTA.
  • Emerging countries need to work in collaboration with other jurisdictions that have established systems to understand good practices and adapt them for the local context. Once organizational systems are established, wider multi-stakeholder engagement is possible.

The second report, HTA: from Reacting to Innovation to Proactively Involved in Technology Development. Lessons Learnt and Ways Forward, dove into patients’ perspectives, explored EUnetHTA Early Dialogues and Beyond, CADTH’s Scientific Advice Program and Early Scientific Advice at Health Canada.
Key points include:

  • Patients believe that all stakeholders should proactively contribute to value-based research, which considers the end-game (HTA), reduces the innovation gap and brings better treatments to patients faster.
  • Industry values EUnetHTA Early Dialogues but consistent high quality needs to be assured, with a consolidated report of convergent and divergent views to inform evidence generation plans.
  • The CADTH Scientific Advice Program uses a flexible process that provides specific advice to influence evidence generation plans and the overall process can identify advances in technologies and analytical methods for which CADTH should prepare.
  • New investments in Canada will help build capacity for the regulator (Health Canada), CADTH and other partners to work together to influence evidence generation plans.

We’d like to extend a special thank you Karen Facey for preparing both of these reports. Expect to see additional reports from more panel sessions in the future!